RARA and neoplasm: Therefore, we mainly used large-scale genomic data from the Cancer Genome Atlas (TCGA) to perform pan-cancer analysis of RARA-AS1, including its expression patterns by comparisons between tumor and normal samples, as well as its relationship with survival via univariate cox regression analyses.